
Insmed
Biopharmaceutical company in Bridgewater, NJ, transforming lives of patients with serious diseases.
- 736
- Public company
- Bridgewater, NJ, USUnited States
Insmed Incorporated, founded in Bridgewater, New Jersey, is a biopharmaceutical company dedicated to transforming the lives of patients with serious and rare diseases. Their core mission is to develop and commercialize innovative therapies that address unmet medical needs. Insmed offers ARIKAYCE for treating Mycobacterium avium complex lung disease and is developing Brensocatib for bronchiectasis, cystic fibrosis, and other neutrophil-mediated diseases. The company focuses on providing life-changing solutions for patients globally.
Notable figures associated with Insmed include its leadership team and key investors who support its mission to advance medical science. The company has achieved significant milestones, including the successful commercialization of ARIKAYCE and ongoing clinical trials for Brensocatib. Insmed's impact is profound, as it continues to make a difference in the lives of patients worldwide through its commitment to daring science and a collaborative culture.
Similar Companies

Pulmatrix
pulmatrix.com

MediciNova
medicinova.com

Renovion
renovion.com

MannKind
mannkindcorp.com

Theravance Biopharma
theravance.com

Amphastar Pharmaceuticals
amphastar.com

Vertex Pharmaceuticals
vrtx.com
Inception Sciences

Genoa Pharmaceuticals
Medinox
medinox.com

Assertio Holdings

Aridis Pharmaceuticals
aridispharma.com

Amicus Therapeutics
amicusrx.com

Innovation Pharmaceuticals
ipharminc.com

Bridge Medicines

CorMedix
cormedix.com

Astria Therapeutics
astriatx.com

Boston Biopharma

Vast Therapeutics

Avalyn Pharma
avalynpharma.com
Quick Facts
Who are Insmed's competitors?
Companies similar to Insmed include Pulmatrix, MediciNova, Renovion and MannKind.
When was Insmed founded?
Insmed was founded in 1999.
Where is Insmed's headquarters located?
Insmed's headquarters is located in Bridgewater, NJ, US.
When was Insmed's last funding round?
Insmed's most recent funding round was for $500k (USD) in May 2023.
How much disclosed funding has Insmed raised?
As of May 8, 2023, Insmed has disclosed funding of $3B (USD). Undisclosed round amounts are excluded.
How many employees does Insmed have?
Insmed has 736 employees as of Feb 6, 2024.
Classification
- Ownership
- Technology
- Geographic Exposure
- Customer
- Main Product
- Also Known As
- Insmed Incorporated
- INSMED Inc
- Headquarters
- 700 US Highway 202/206
- Bridgewater, NJ, 08807
- US
- Ticker
- INSM
- SEC CIK
- 0001104506
- EIN
- 54-1972729
- NAICS
- 540000Professional, Scientific, and Technical Services
- 541714Research and Development in Biotechnology (except Nanobiotechnology)
- 541000Professional, Scientific, and Technical Services
- 541700Scientific Research and Development Services
- 541710Research and Development in the Physical, Engineering, and Life Sciences
- SIC
- 2800Chemicals And Allied Products
- 2830Drugs
- 2834Pharmaceutical Preparations
- ISIC
- 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
- Industry
- —Biotechnology Companies
- —Health Care Companies
- —Medical Organizations
- —Pharmaceutical Companies
Show 16 more industry codes
- NAICS
- 320000Manufacturing
- 325400Pharmaceutical and Medicine Manufacturing
- 620000Health Care and Social Assistance
- 325000Chemical Manufacturing
- 623000Nursing and Residential Care Facilities
- 325410Pharmaceutical and Medicine Manufacturing
- 325412Pharmaceutical Preparation Manufacturing
- 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SIC
- 4000Railroad Transportation
- 8000Health Services
- 8700Engineering, Accounting, Research, Management, And Related Services
- 8040Offices And Clinics Of Other Health Practitioners
- 8730Research, Development, And Testing Services
- 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
- 8731Commercial Physical and Biological Research
- ISIC
- 7210Research and experimental development on natural sciences and engineering